Anaplastic lymphoma kinase (ALK) inhibitors for second-line therapy of non-small cell lung cancer

Thierry Berghmans,1 Myriam Remmelink,2 Ahmad Awada31Clinic of Thoracic Oncology and Department of Intensive Care, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; 2Department of Pathology, Hôpital Erasme, Université Libre de Bruxell...

Full description

Saved in:
Bibliographic Details
Main Authors: Berghmans T, Remmelink M, Awada A
Format: article
Language:EN
Published: Dove Medical Press 2012
Subjects:
Online Access:https://doaj.org/article/bd7cdb1d05854b19b7235edc51419c23
Tags: Add Tag
No Tags, Be the first to tag this record!